Budesonide led to a greater remission rate and fewer severe adverse events than did mesalamine in Crohn's disease

Antzeko izenburuak

• Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis
  nork: HANAUER, S
  Argitaratua: (1999)
• Omeprazole led to greater remission rate than misoprostol for ulcers associated with non-steroidal anti-inflammatory drugs
  nork: LANGMAN, M
  Argitaratua: (1998)
• Budesonide for maintenance of remission in Crohn's disease
  nork: Kuenzig, M Ellen, et al.
  Argitaratua: (2014)
• Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease
  nork: Herfarth, H, et al.
  Argitaratua: (2006)
• Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir
  nork: Smith, Christiana, et al.
  Argitaratua: (2016)